If you would like to learn more about future focusIR related events and roundtables, please submit your details here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksBbva Ord Regulatory News (BVA)

Share Price Information for Bbva Ord (BVA)

Share Price is delayed by 15 minutes
Get Live Data
22.10    0.20 (0.91%)
Bid:
22.10
Ask:
23.20
Spread: 1.10 (4.977%)
Market Cap: €122.52b
BVA Live PriceLast checked at - London Stock Exchange

Intraday Bbva Ord Share Chart

BBVAs share capital reduction

31 Mar 2026 17:50

RNS Number : 9322Y
Banco Bilbao Vizcaya Argentaria SA
31 March 2026
 

Banco Bilbao Vizcaya Argentaria, S.A. ("BBVA" or the "Company"), in compliance with the securities market legislation, hereby communicates the following:

 

OTHER RELEVANT INFORMATION

 

Notice is hereby given of the partial execution of the share capital reduction resolution adopted by the Ordinary General Shareholders' Meeting of BBVA held on 20 March 2026, under agenda item five, through the reduction of BBVA's share capital in a nominal amount of 36,732,017.98 euros, by means of the cancellation of 74,963,302 own shares of 0.49 euros par value each held by the Company as treasury shares.

 

The own shares subject to the cancellation were acquired derivatively by the Company in execution of the first tranche of the program scheme for the repurchase of own shares, which were communicated by means of inside information dated 19 December 2025 (registration number 3,046). The completion of the first tranche of the program scheme for the repurchase of own shares was communicated by BBVA as other relevant information on 6 March 2026 (registration number 39,596).

 

Following the cancellation of the 74,963,302 own shares with a par value of 36,732,017.98 euros, BBVA's share capital has been set at 2,760,662,645.02 euros, represented by 5,634,005,398 shares with a par value of 0.49 euros each.

 

This capital reduction does not entail the return of contributions, since the Company itself is the owner of the redeemed shares, and is charged to unrestricted reserves, through the allocation of the reserve for redeemed capital for an amount equal to the par value of the redeemed shares, which can only be used under the same conditions as those required for the reduction of the share capital, in application of the provisions of Article 335 c) of the Spanish Companies Act. Consequently, the Company's creditors will not have the right of opposition referred to in Article 334 of the Spanish Companies Act.

 

Likewise, notice is hereby given that BBVA will request the delisting of the redeemed shares from the relevant Stock Exchanges and the cancellation of the redeemed shares in the accounting records of "Sociedad de Gestión de los Sistemas de Registro, Compensación y Liquidación de Valores, S.A." (Sociedad Unipersonal) (IBERCLEAR).

 

 

Madrid, 31 March 2026

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
MSCEAKDFDLKKEFA
Date   Source Headline
1st Feb 20187:09 amRNS4Q17 Results Presentation
1st Feb 20187:04 amRNS4Q17 Results Report
1st Feb 20187:02 amRNS4Q17 Results Press Release
1st Feb 20187:00 amRNSProposal for payment of dividend
25th Jan 20185:25 pmRNS4Q17 Results Presentation Announcement
10th Jan 20187:00 amRNSAssessment of the shareholding at Telefonica, S.A
28th Dec 20173:26 pmRNSGMTN Programme Supplement to the Offering Circular
27th Dec 201712:59 pmRNSGMTN Programme - Issuer Substitution
27th Dec 201712:42 pmRNSGMTN Programme
21st Dec 20176:29 pmRNSPost Stabilisation Notice
15th Dec 20174:00 pmRNSPublication of approved ECP Information Memorandum
13th Dec 20175:35 pmRNSSREP Capital Requirements 2018
5th Dec 20177:22 amRNSTransmissions and purchases of capital undertaking
4th Dec 201710:47 amRNSFinal Terms 154SNP
29th Nov 20178:13 amRNSSale of real estate business
28th Nov 20177:00 amRNSBinding offer for the acquisition of BBVA Chile
24th Nov 20171:25 pmRNSFinal Terms 153SNP
10th Nov 201712:31 pmRNSFinal Terms Global Medium Term Note Programme
9th Nov 20177:00 amRNSAT1 Issuance for a total nominal amount
8th Nov 201710:52 amRNSPre Stabilisation Notice
7th Nov 20171:10 pmRNSOffer of securities contingently convertible
27th Oct 20174:29 pmRNSGMTN programme Supplement to the Offering Circular
27th Oct 20177:00 amRNSBBVA communicates its 3Q17 results presentation
27th Oct 20177:00 amRNSBBVA communicates its 3Q17 results report
27th Oct 20177:00 amRNSBBVA communicates its 3Q17 results press release
23rd Oct 20175:33 pmRNS3Q17 Results Presentation Announcement
6th Oct 201711:39 amRNSPost Stabilisation Notice BBVA EUR 5yr SNP
28th Sep 20177:55 amRNSHR News Real Estate
28th Sep 20177:00 amRNSDividend October 2017
4th Sep 20174:33 pmRNSFinal Terms 152 Execution version
31st Aug 20177:47 amRNSBBVA Chile News
30th Aug 20178:30 amRNSPre Stabilisation Notice BBVA 5yr EUR SNP
2nd Aug 20177:57 amRNSDBRS upgrades BBVA´s Cédulas Hipotecarias rating
1st Aug 201712:53 pmRNSFinal Supplement 2Q17
27th Jul 20176:04 pmRNS2Q17 Results Report
27th Jul 20175:46 pmRNS2Q17 Results Presentation
27th Jul 20175:30 pmRNS2Q17 Results Press Release
25th Jul 20175:39 pmRNSScope upgrades BBVA's senior unsecured rating
20th Jul 20175:18 pmRNSResults Presentation Announcement
12th Jun 20177:00 amRNSDBRS changes subordinated debt ratings
1st Jun 20177:00 amRNSBoard of Directors changes
25th May 201712:32 pmRNSFinal Terms GMTN151SUB
25th May 201711:26 amRNSFinal Terms
17th May 20177:00 amRNSAT1 Issuance
5th May 201712:55 pmRNSDividend Option
3rd May 201711:58 amRNSsupplemental to the Offering Circular
28th Apr 20178:43 amRNS2016 Audited Financial Statements
27th Apr 20177:00 amRNS1Q17 Results Report
27th Apr 20177:00 amRNS1Q17 Results Presentation
27th Apr 20177:00 amRNS1Q17 Press Release

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.